Godavari Biorefineries Patent
Godavari Biorefineries Ltd has been granted a US patent for a compound targeting cancer treatment. This patent covers a novel class of cancer-inhibiting compounds.
ALFA Filings
Every announcement, straight from the exchange
Every Godavari Biorefineries patent announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Godavari Biorefineries Ltd has been granted a US patent for a compound targeting cancer treatment. This patent covers a novel class of cancer-inhibiting compounds.
Godavari Biorefineries Limited has been granted a patent by the Mexican Patent Office for its invention concerning compounds for treating viral infections.
China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.
Godavari Biorefineries Ltd announced that the Japanese Patent Office granted its patent “5‑HYDROXY‑1,4‑NAPHTHALENEDIONE for use in cancer treatment.” The grant enhances the company’s IP portfolio for oncology therapeutics.
Godavari Biorefineries was granted an Indian patent for a safe, cost-effective branched alcohol production process. This grant strengthens its bio-based chemicals intellectual property portfolio.